Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Immunology

Background:

• Atherosclerosis and aortic valve sclerosis are prevalent cardiovascular diseases.
• Current treatments for atherosclerosis (statins) are ineffective for aortic valve sclerosis, leaving surgery as the only option for severe cases.
• Both conditions are inflammatory diseases linked to lipid deposition, not merely degenerative processes.

Purpose of the Study:

• To review experimental findings on p38 mitogen-activated protein kinase (MAPK) in atherosclerosis and aortic valve sclerosis.
• To discuss the potential roles of p38 MAPK in disease progression.
• To evaluate p38 MAPK as a potential pharmacological target.

Main Methods:

• Literature review of experimental studies on p38 MAPK in atherosclerosis and aortic valve sclerosis.
• Analysis of the involvement of p38 MAPK signaling in inflammatory processes within vascular and valvular lesions.

Main Results:

• p38 MAPK is activated by stimuli abundant in atherosclerotic and aortic valve sclerotic lesions, such as oxidative stress and cytokines.
• p38 MAPK signaling elicits diverse responses in different cell types within these lesions.
• These diverse responses may contribute to the progression of atherosclerosis and aortic valve sclerosis.

Conclusions:

• The p38 MAPK pathway is significantly involved in the inflammatory mechanisms underlying atherosclerosis and aortic valve sclerosis.
• Understanding the specific roles of p38 MAPK in different cell types is crucial.
• p38 MAPK represents a promising pharmacological target for treating these cardiovascular diseases.